In This Article:-Chinese SinoVac Biotech Ltd. (Nasdaq: SVA) shares have been frozen since 2019 amid shareholder disputes when market cap was about $500 million-SinoVac developed a wildly successful C… [+148 chars]...
Read moreBEIJING Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that it received a resignation notice from David Guowei… [+5893 chars]...
Read moreSends Open Letter to Sinovac Shareholders Calling for a New Board to End Years of Chaos at Sinovac THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city a… [+8124 chars]...
Read moreSAIF Partners Nominees Will Work Proactively to Help Shareholders Realize Full Value of Sinovac, Including Through the Payment of Significant Dividends and Resumption of Trading of Common Shares THI… [+9081 chars]...
Read moreDublin, June 19, 2025 (GLOBE NEWSWIRE) -- The "Human Papillomavirus (HPV) Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market f… [+10234 chars]...
Read more